Elecsys® Anti-SARS-CoV-2 is an immunoassay for the in vitro qualitative detection of antibodies (including IgG) to SARS-CoV-2 in human serum and plasma. The assay uses a recombinant protein representing the nucleocapsid (N) antigen in a double-antigen sandwich assay format, which favors detection of high affinity antibodies against SARS-CoV-2. Elecsys® Anti-SARS-CoV-2 detects antibody titers, which have been shown to positively correlate with neutralizing antibodies in neutralization assays. The test is intended as an aid in the determination of the immune reaction to SARS-CoV-2.45
- Testing time: 18 minutes
- Serum collected using standard sampling tubes or tubes containing separating gel.
- 14 days onboard stability
Elecsys Anti-SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy Elecsys Anti-SARS-CoV-2 for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring Elecsys Anti-SARS-CoV-2 for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for Elecsys Anti-SARS-CoV-2 for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.